SONO TEK CORP (SOTK) Form 8-K — Oct 14, 2026
$SOTKForm 8-KItems 2.02, 7.01, 9.01Filed Oct 14, 2026, 7:10 AM ET0001171520-26-000304Original filing
Sono-Tek (SOTK) reported fiscal Q2 and first-half 2027 results with H1 revenue up 6% to $10.89 million, gross margin expanding to 55% from 51%, and operating income up 41% to $1.28 million. Medical was the standout driver, with H1 medical sales up 289% to $7.05 million on balloon coating and stent-coating systems, while clean energy sales fell 85% amid U.S. policy shifts. Backlog rose 23% sequentially to $9.51 million, and three post-quarter orders totaling roughly $7.19 million materially improve FY2028 revenue visibility.
Key figures
- Eps
- 0.07
- Revenue
- 10893000
- Guidance
- Reiterates flat to modest revenue growth for FY 2027
- Net Income
- 1107000
- Revenue Yoy
- 6% (H1 FY27)
- Total Assets
- 26399575
- Cash Position
- 17700000
- Shares Outstanding
- 15716723
- Debt
- None outstanding
- Backlog
- $9.51M (+23% sequentially)
- Q2 revenue
- $5.23M (+1% YoY)
- Q2 net income
- $366,000 vs $424,000 prior year (-14%)
- Q2 eps diluted
- $0.02 vs $0.03
- H1 gross margin
- 55% vs 51%
- Q2 gross margin
- 53% vs 50%
- Medical h1 sales
- $7.05M (+289%)
- Subsequent orders
- $7.19M (three orders expected to ship in FY 2028)
- H1 operating income
- $1.28M (+41%)
- Alternative energy h1 sales
- $855,000 (-85%)
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.